Waters Corporation (NYSE:WAT) Director William J. Miller sold 3,500 shares of Waters stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $194.94, for a total transaction of $682,290.00. Following the sale, the director now owns 25,849 shares of the company’s stock, valued at $5,039,004.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Waters Corporation (WAT) traded up $2.82 during midday trading on Friday, reaching $199.29. 329,600 shares of the company were exchanged, compared to its average volume of 513,724. The firm has a market capitalization of $15,830.00, a P/E ratio of 27.11, a PEG ratio of 2.83 and a beta of 0.82. Waters Corporation has a 52 week low of $133.71 and a 52 week high of $201.95. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.03. Waters had a net margin of 24.34% and a return on equity of 23.61%. The company had revenue of $565.58 million during the quarter, compared to the consensus estimate of $555.25 million. During the same period in the previous year, the firm posted $1.57 earnings per share. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. equities analysts predict that Waters Corporation will post 7.42 earnings per share for the current year.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Oppenheimer Asset Management Inc. increased its holdings in Waters by 0.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after buying an additional 2 shares in the last quarter. ETF Managers Group LLC purchased a new position in Waters in the second quarter valued at $106,000. Intellectus Partners LLC increased its holdings in Waters by 4.9% in the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock valued at $123,000 after buying an additional 31 shares in the last quarter. First Manhattan Co. purchased a new position in Waters in the second quarter valued at $130,000. Finally, Edmond DE Rothschild Holding S.A. purchased a new position in Waters in the second quarter valued at $160,000. 92.29% of the stock is owned by institutional investors.

Several research firms have recently commented on WAT. Morgan Stanley upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price objective for the company in a research note on Monday. Cowen reiterated a “hold” rating and set a $190.00 price objective on shares of Waters in a research note on Friday, November 3rd. Bank of America lifted their price objective on shares of Waters from $192.00 to $202.00 and gave the stock a “neutral” rating in a research note on Friday, November 10th. Zacks Investment Research downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Thursday, October 26th. Finally, Citigroup restated a “neutral” rating and set a $180.00 target price on shares of Waters in a research report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $193.62.

TRADEMARK VIOLATION WARNING: This piece was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/waters-corporation-wat-director-william-j-miller-sells-3500-shares-of-stock/1752720.html.

About Waters

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.